Filed Oct. 28, 2025

Serial No. 99464862

Examining Attorney MELISSA C VALLILLO

Class Pharmaceutical, medicinal, veterinary and therapeutic preparations and substances for use in the treatment of cancer; pharmaceutical preparations and substances being reagents for medical diagnosis; pharmaceutical preparations and substances for therapy and treatment of cancer; pharmaceutical, medicinal, veterinary and therapeutic preparations and substances for theranostics; pharmaceutical preparations and substances for facilitating the delivery of pharmaceutical and medicinal preparations and substances; radiopharmaceuticals for use in the diagnosis and treatment of cancers; radioprotectors being pharmaceutical preparations for use in the treatment of cancer; radiopharmaceuticals for use in theranostics; radiopharmaceutical preparations for use in the treatment of cancer; radiopharmaceutical medical diagnostic preparations and therapeutic preparations for medical purposes for use in the treatment of cancer; radiopharmaceuticals for medical and clinical use for use in the treatment of cancer; radiopharmaceutical preparations for nuclear medicine for use in the treatment of cancer; radiopharmaceutical preparations and substances for use in oncology, namely radiopharmaceuticals for diagnosing and treating cancer; radiopharmaceuticals, particularly for the treatment of cancer; radio therapeutic preparations for use in the treatment of cancer; chemical substances and preparations being radioactive substances for medical purposes for use in the treatment of cancer; radioisotopes for medical purposes for use in the treatment of cancer; medical diagnostic radioisotopes and radiochemicals and therapeutic radioisotopes and radiochemicals for medical purposes for use in the treatment of cancer; radiopharmaceutical preparations and substances for endo-radionuclide therapy and brachytherapy; radiopharmaceuticals used in the field of nuclear medicine, namely, medical imaging and for use as therapy for use in the treatment of cancer; radiopharmaceutical preparations and substances for positron emission tomography; radiopharmaceutical preparations and substances for single photon emission tomography, target radionuclide and peptide receptor radionuclide therapy; theranostics being pharmaceutical preparations for use in the field of oncology; theranostics being pharmaceutical preparations for use in the field of precision oncology; radiopharmaceutical preparations for use in oncology, namely radiopharmaceuticals containing radioisotopes for treatment and diagnosis of tumours; target radiopharmaceuticals containing a target molecule for use in the treatment of cancer; preparations for targeted radionuclide therapy for use in the treatment of cancer; therapeutic agents for delivery of radioactive material to target sites within the body; irradiated or radioactive microspheres being pharmaceutical preparations used for therapeutic medical purposes for use in the treatment of cancer; radiopharmaceuticals for use in the imaging, diagnosis and therapy of cancer, osteosarcoma, bone metastases, prostate cancer, breast cancer, brain cancer, ovarian cancer, lung cancer, testicular cancer, renal cancer, bladder cancer, kidney or renal cancer, fallopian tube cancer, uterine leiomyoma, non-Hodgkin's lymphoma, colon cancer, lipoma, basal cell skin carcinoma, squamous cell skin carcinoma, acute myelogenous leukemia, pancreatic cancer, central nervous system cancer, retinoblastoma, neuroblastoma, glioblastoma, Kaposi's sarcoma, Ewing's sarcoma, rhabdomyosarcoma, hermangioma, solid tumours, blood-borne tumours, leukemia and melanoma; radiopharmaceuticals containing radioisotopes with short half-lives for medical diagnostic applications; chemicals for pharmaceutical use for use in the treatment of cancer; chemicals being radiopharmaceuticals for medical diagnostic uses; pharmaceutical drugs for use in the treatment of cancer; pharmaceutical preparations for the treatment of cancer; radiopharmaceuticals for use with highly sensitive molecular imaging technologies such as positron emission tomography or single photon emission tomography; 005; 006; 018; 044; 046; 051; 052; 026; 039; 044; 100; 101

Case Type Trademark Service mark